top of page
Insights and News Curated for Life Science Experts by Life Science Experts....
INSIGHTS HUB
Warren Buffett’s Hiring Rule: Why Integrity Comes First
Warren Buffett’s hiring philosophy has long been quoted in business circles, and for good reason. As he prepares to step down as CEO of...
Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry
As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...
The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective
In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...
Search
Bain Capital to Buy Olympus Science-Optics Unit for $3.1 Billion
New York City, NY, August 29, 2022 (Bloomberg) -- Bain Capital agreed to buy Olympus Corp.’s scientific instruments business for 428...
Digital Diagnostics Closes $75 million Series B Funding Round led by KKR
Coralville, IA, August 23, 2022 (PRNewswire) -- Digital Diagnostics, a leading artificial intelligence diagnostic health care...
Orna Therapeutics Raises $221 Million Series B
Cambridge, MA, August 16, 2022 (PRNewswire) -- Orna Therapeutics, a biotechnology company pioneering a new class of fully engineered...
Gilead to Acquire Remaining Worldwide Rights of Trodelvy®
Foster City, CA, August 15, 2020 (BUSINESS WIRE) -- Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with Everest...
Philips Names New CEO Who Has Led Respiratory Device Recall
New York City, NY, August 16, 2020 (Bloomberg) -- Royal Philips NV said Roy Jakobs, who has been leading the company’s response to a...
Sanofi and Atomwise Ink Deal Worth over $1B
San Francisco, CA, July 17, 2020 (BUSINESS WIRE) -- Atomwise, a leader in using artificial intelligence (AI) for small molecule drug...
Poseida inks deal with Roche for $110M initially and potentially $6B in aggregate value.
San Diego, CA, August, 3, 2022 (street insider) — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company...
IDRx Launches with $122 Million Series A Financing to Treat Cancer with Purpose-Built Precision Comb
IDRx aims to develop precision cancer medicines with a priori engineered, selective combinations to stop key tumor escape mechanisms and...
Sironax Announces Closing of $200 Million Series B Financing
Financing from new and existing investors will support pipeline progression and expansion for age-related degenerative diseasess BEIJING,...
Vico Therapeutics Appoints Micah Mackison as Chief Executive Officer
LEIDEN, Netherlands, Aug. 1, 2022 (PRNewswire) — Vico Therapeutics B.V., a neurology-focused genetic medicine company, today announced...
Pleco Therapeutics Announces Expansion with the Incorporation of a U.S. Subsidiary and the Appointme
Nijmegen, Netherlands and Newark, N.J., July 26, 2022 (PRNewswire) — Pleco Therapeutics BV, a specialty biopharmaceutical company...
BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies
San Mateo, CA, July 20, 2022 (BUSINESS WIRE) — BigHat Biosciences, a biotechnology company developing safer, more effective antibody...
CAMP4 Secures $100 Million Series B Financing to Accelerate Expansion of its Novel Regulatory RNA-Ta
Cambridge, MA., July 20, 2022 (BUSINESS WIRE) — CAMP4 Therapeutics, a biotechnology company harnessing the power of RNA to restore...
Conventus Flower Orthopedics Appoints Bradley Niemann as Chief Executive Officer
Horsham, PA., July 19, 2022 (PRNewswire) — Conventus Flower Orthopedics, a privately held medical technology company that pioneered the...
Delfi Diagnostics Announces $225 Million Series B Financing to Develop Globally Accessible Portfolio
Baltimore and Palo Alto, CA., July 18, 2022 (PRNewswire) — Delfi Diagnostics, Inc., a pioneering developer of a new class of...
NRx Pharmaceuticals Announces the Appointment of Stephen Willard, Chief Executive Officer and Direct
Radnor, PA., July 13, 2022 (PRNewswire) — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP): (“NRx Pharmaceuticals”, or the “Company”), a...
Boehringer, Evotec and BioMeriuex pump €40M into new venture Aurobac Therapeutics
Ingelheim & Hamburg, DE & Marcy-L’Étoile, FR, July 06, 2022 (Business Wire) — Boehringer Ingelheim, a leading research-driven...
Orchestra BioMed™ Announces Strategic Collaboration, Closing of $110 Million Private Equity Financin
New Hope, PA. and New York, NY, July 05, 2022 (GLOBE NEWSWIRE) — Orchestra BioMed™, Inc. (“Orchestra BioMed”), a biomedical company...
Life Science Headlines - February 2nd, 2022
Welcome to Life Science Headlines (formerly Healthcare Headlines). As some of you know, in 2014 Jacobs Management Group launched an...
Life Science Headlines - January 20th, 2022
Welcome to Life Science Headlines (formerly Healthcare Headlines). As some of you know, in 2014 Jacobs Management Group launched an...
bottom of page